FAQs

There were an estimated 655,000 malaria deaths in 2010. Approximately 86% of malaria deaths...

MMV’s R&D activities are not conducted on our own premises. Instead we use our partners’...

For a comprehensive answer, please watch our...

MMV does not provide grants for projects, but usually has an annual call for proposals during...

When MMV enters into contractual relationships with its partners, its primary goal is to ensure...

Killing the mosquitoes that transmit malaria – vector control – is an established method for...

MMV’s strong commitment to quality is in line with our regulatory strategy. Our aim is to ensure...

MMV works with partners within the scope of its mission, to reduce the burden of malaria in...

Information about MMV's...

Job vacancies are posted in jobs section of...

MMV recognizes that the pharmaceutical industry is the keeper of all knowledge and expertise...

Several organizations are involved in the fight to defeat malaria. In part this is because it is...

MMV has received funding and support from government agencies, private foundations,...

Defeating malaria requires a comprehensive approach. There is no magic bullet. Insecticide...

MMV works with a commercial partner through all phases of the R&D process, from early...

No. MMV was founded following discussions between several organizations, including the WHO....

Drug development is invariably risky. In developing these different artemisinin combination...